T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity
A multi-layered, virus-specific immune response is important for controlling SARS-CoV-2 during the acute phase of the infection and reducing COVID-19 disease severity, with the bulk of the evidence pointing to a much bigger role for T cells than antibodies. A weak or uncoordinated immune response, on the other hand, predicts a poor disease outcome.
Read Original Article: T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity »
